Diabetes

Stelo by Dexcom: Glucose Biosensor System

Date: January 29, 2025

Speaker(s): 

• Priscilla Ly, PharmD Candidate

Learning Objectives:

1. Identify the different types of continuous glucose monitors available 

2. Instruct patients on how to apply, set up, and use Stelo CGM

3. Navigate the Stelo app to interpret CGM results 

4. Determine who may benefit from a Stelo CGM 

Updates from the 84th American Diabetes Association Scientific Sessions (2024)

Recording available here 

Date: July 2024

Speaker(s): 

• Alexandra Polito, PharmD, BCACP

Learning Objectives: Landmark Trials

1. SELECT

2. SURMOUNT

3. STEP-HF

4. FLOW

5. TIGHT

Diabetes Care: The Power of Language in Reducing Stigma

Recording available here 

Date: September 19, 2023

Speaker(s): 

• Rebecca Schein, PharmD Candidate

Learning Objectives:

1. Guiding Principles

2. Why It's Important?

3. Patient Case/Discussion

4. Provider Resources

5. Conclusion

Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis

Recording available here 

Date: September 19, 2023

Speaker(s): 

• Dr. Limor Ouziel-Yahalom from Eli Lilly  

Learning Objectives:

1. Review clinical trial data for the following trial: Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis

Management of T2DM in ESRD

Recording available here 

Date: February 8, 2023

Speaker(s): 

• Olivia Arnold P4 APPE Student University of Rhode Island

Learning Objectives:

1. Evaluate a clinical case

2. Discuss ESRD in T2DM

3. Determine nonpharmacological managment options

4. Determine appropriate managment options

Supplemental Materials:

• 2022 KDIGO Updates 

• Managment of T2DM in ESRD Overview 

Personal Continuous Glucose Monitors

Date: September 13, 2022

Speaker(s): 

• Emily Zouzas, PharmD, BCACP

• Qitong (Coco) Yang P4 APPE Student Northeastern University

Learning Objectives:

1. Understand the use of personal CGMs in patients with diabetes

2. Be familiar with the differences between Dexcom G6, Freestyle Libre 14-day, and Freestyle Libre 2

3. Instruct patients on how to apply, set up, and use CGMs at home

4. Understand how to view and interpret CGM results screen 

5. Instruct patients on CGM precautions and how to prevent and manage skin irritation

New Drug Update: Tirzepatide (Mounjaro)

Recording available here 

Date: June 21, 2022

Speaker(s): 

• Charlotte Brochu, PharmD

  • PGY1 Pharmacy Resident - Cambridge Health Alliance

Learning Objectives:

1. Describe tirzepatide’s mechanism of action, adverse effects, and safety profile.

2. Interpret primary literature to compare tirzepatide to other relevant treatments for type 2 diabetes (T2D) and obesity.

3. Review indications, dosing, and contraindications for tirzepatide.

4. Identify current gaps in knowledge and upcoming trials that will assess tirzepatide therapy.

SGLT2i Use: The Sweet and Salty

Recording available here 

Date: May 21, 2022

Speaker(s): 

• Catrina Derderian, PharmD, BCACP, DPLA

  • Senior Clinical Pharmacist Specialist - Pharmacotherapy Services 

• Lauren Sullivan, PharmD, BCACP

  • Clinical Pharmacist Specialist - Pharmacotherapy Services 

Learning Objectives:

1. Interpret sodium-glucose cotransporter 2 inhibitors (SGLT2i) landmark studies with regard to patient selection, outcomes, and adverse events.

2. In a patient with heart failure (HF), develop a treatment plan to adjust other HF medications when initiating or adjusting SGLT2i.

3. Describe renal effects of SGLT2i and list appropriate dosing thresholds in patients with chronic kidney disease (CKD).

4. Employ validated strategies to safely prescribe SGLT2i in patients with an elevated risk for adverse drug reactions.

Let's Get Personal...About Continuous Glucose Monitoring in Type 2 Diabetes

Recording available here 

Date: July 13, 2021

Speaker(s):

• Alexandra Polito, PharmD, BCACP

  • Senior Clinical Pharmacist Specialist - Pharmacotherapy Services 

• Alexandra Santamaria, PharmD, CDE

  • Senior Clinical Pharmacist Specialist - Pharmacotherapy Services 

Learning Objectives:

1. Describe how continuous glucose monitors (CGMs) measure glucose and how this contrasts with traditional blood glucose monitoring methods.

2. List different categories of CGMs available for the management of type 2 diabetes mellitus (T2DM).

3. Compare commercially available CGMs with regard to required components, product features, and patient counseling points.

4. Given a patient case, identify an appropriate CGM device to optimize diabetes monitoring.

5. Examine the primary literature regarding the effect of CGMs on glycemic control and quality of life outcomes

6. Differentiate between pharmacist and pharmacy technician responsibilities from a CGM training checklist.

Up Close and Personal - with Continuous Glucose Monitor Reports

Recording available here 

Date: July 22, 2021

Speaker(s):

• Alexandra Polito, PharmD, BCACP

  • Senior Clinical Pharmacist Specialist - Pharmacotherapy Services 

• Alexandra Santamaria, PharmD, CDE

  • Senior Clinical Pharmacist Specialist - Pharmacotherapy Services 

Learning Objectives:

1. Identify the available application and cloud based methods for sharing patient continuous glucose monitoring (CGM) data

2. Define appropriate CGM targets for patients with T2DM

3. Interpret CGM metrics from LibreView and Clarity reports

4. Apply appropriate strategies to effectively review CGM data with a patient

5. Given a patient case, employ CGM metrics to design and optimize a therapeutic drug regimen for T2DM

Going with the FLO-zins: The Evolving Role of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors

Recording available here 

Date: May 20, 2021

Speaker(s):

• Durga Dahal, PharmD

  • PGY1 Pharmacy Resident - Cambridge Health Alliance

Learning Objectives:

1. Identify the proposed underlying mechanisms through which SGLT2 inhibitors exert cardiovascular and renal benefits

2. Describe adverse effects, safety, and monitoring parameters of SGLT2 inhibitors

3. Compare baseline characteristics and outcomes of landmark cardiovascular and cardiorenal outcome trials for SGLT2 inhibitors

4. Given a patient case, employ evidence-based medicine to design a therapeutic diabetes treatment plan

Managing Diabetes During Ramadan

Recording available here (0:00 to 53:00) 

Date: April 27, 2021

Speaker(s):

• Uswa Ahmad, PharmD, BCACP

  • Clinical Pharmacist Specialist - Pharmacotherapy Services 

Learning Objectives:

1. Discuss the significance of fasting in the Islamic faith

2. Identify the risks associated with fasting in patients with diabetes

3. Categorize diabetic patients according to their risk of complications due to fasting

4. Construct safe management plans for fasting diabetic patients

Monitoring Blood Sugar in Dialysis Patients with Diabetes

Recording available here 

Date: November 19, 2020

Speaker(s):

• Rita Ejiofor, PharmD Candidate 2021

  • Pharmacy Student - University of Connecticut

Learning Objectives:

1. Describe the effects of dialysis on glycemic control.

2. Recognize potential inaccuracies of standard blood sugar monitoring in dialysis patients with diabetes.

3. Identify alternative testing methods to measure blood glucose in dialysis patients with diabetes.

A Look at GLP-1 Agonists and Their Effects on the Liver

Recording available here 

Date: October 22, 2020

Speaker(s):

• Brylee McLaughlin, PharmD Candidate 2021

  • Pharmacy Student - University of Connecticut

Learning Objectives:

1. List the potential benefits of GLP-1 agonists in nonalcoholic fatty liver disease (NAFLD)

2. Discuss appropriate therapy options for a patient with uncontrolled diabetes and NAFLD

3. Describe a treatment plan for a patient on a GLP-1 agonist with elevated alkaline phosphatase